Brief: Positive Development In Nanexa’s Patent Litigation Case
18/03/2022 06:17
March 18 (Reuters) - Nanexa AB NANEXA.ST :
* SAID ON THURSDAY THE UNITED STATES DISTRICT COURT FOR THE
DISTRICT OF DELAWARE DENIED VITRIVAX’S MOTION TO DISMISS
NANEXA’S COMPLAINT FOR PATENT INFRINGEMENT AND DENIED AS MOOT
VITRIVAX’S MOTION TO STAY DISCOVERY
* NANEXA’S MOTION TO COMPEL DISCOVERY WAS GRANTED
* NANEXA WILL CONTINUE TO ACTIVELY PROTECT ITS VALUABLE
INTELLECTUAL PROPERTY RIGHTS RELATED TO ITS DRUG DELIVERY SYSTEM
PHARMASHELL®.
Source text for Eikon: urn:newsml:reuters.com:*:nMFN7vpqfg
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))